Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.
Brittany A SheltonDeirdre SawinskiShikha MehtaRhiannon D ReedPaul A MacLennanJayme E LockePublished in: Transplant infectious disease : an official journal of the Transplantation Society (2018)
In light of effective HCV therapies, it may be prudent to institute strategies to decrease waiting time and waitlist mortality for HCV+ candidates by increasing utilization of HCV+ donor kidneys.